Myasthenia gravis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who have been diagnosed with myasthenia gravis (MG) as assessed by neurologists in this center or other top-tier hospitals and meet the diagnostic criteria of the 2015 Chinese Myasthenia Gravis Guidelines; 2. Thymus imaging (CT or MR) clearly combined with thymic abnormalities (thymic hyperplasia or thymoma); 3. From January 2021 to December 2022, received expanded thymectomy in the Thoracic Surgery of the Research Center; 4. Subjects voluntarily join the study, agree to collect relevant information including thymus pathology information, and sign an informed consent form (patients under the age of 18 are signed by their legal representatives).
Exclusion criteria
Exclusion criteria: 1. Accompanied by serious underlying diseases, such as liver and kidney failure, heart failure, etc.; 2. Patients with other systemic tumors; 3. Mental illness affects prognosis assessment; 4. According to the judgment of the investigator, there are other patients with accompanying diseases that seriously endanger the safety of the patient or affect the completion of the study; 5. The investigator assesses those who are expected to have poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Masthenia Crsis; | — |
Countries
China
Contacts
The Second Affiliated Hospital of Air Force Medical University